If you purchased shares of BioXcel Therapeutics, Inc. securities between March 9, 2023 and June 28, 2023, both dates inclusive, for the beneficial interest of a Person other than yourself, please read the Broker/Nominee letter below with instructions on how to notify your clients:
| DOCUMENT | DESCRIPTION | SIZE | DOWNLOAD |
|---|---|---|---|
| BioXcel Broker Letter | 546 KB | PDF ↓ |
If you are filing electronic claims:
Representatives with authority to file on behalf of (a) accounts of multiple Settlement Class Members and/or (b) institutional accounts with large numbers of transactions (“Representative Filers”) must submit information regarding their transactions in an electronic spreadsheet format. The instructions and spreadsheet template are below: